Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading SNTA News...
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.81% | 15.78 | 14.2% | $301.90m | |
| SHPG | Shire PLC Sponsored ADR | -1.11% | 172.98 | 0.4% | $213.79m | |
| PRGO | Perrigo Co. Plc | 0.83% | 75.27 | 6.4% | $143.86m | |
| PRXL | PAREXEL International Corporation | -0.36% | 86.80 | 7.9% | $136.24m | |
| MNK | Mallinckrodt Plc | 2.12% | 46.33 | 17.7% | $126.60m | |
| ALR | Alere Inc. | -0.10% | 50.18 | 2.7% | $93.63m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.43% | 158.80 | 2.2% | $84.49m | |
| UTHR | United Therapeutics Corporation | -0.08% | 131.59 | 13.9% | $76.26m | |
| ENDP | Endo International Plc | 1.63% | 11.84 | 8.9% | $73.99m | |
| PTLA | Portola Pharmaceuticals, Inc. | 46.75% | 56.13 | 8.9% | $69.62m | |
| HZNP | Horizon Pharma plc | -1.22% | 11.73 | 7.6% | $57.17m | |
| AERI | Aerie Pharmaceuticals, Inc. | -0.45% | 54.80 | 8.9% | $55.00m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.32% | 132.29 | 22.1% | $52.53m | |
| MDCO | Medicines Company | 1.18% | 38.60 | 22.3% | $51.68m | |
| CTLT | Catalent Inc | -1.53% | 37.22 | 2.8% | $40.04m |
Company Profile
Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.,0GF79X-E